|
1
|
Klagsbrun M and Eichmann A: A role for
axon guidance receptors and ligands in blood vessel development and
tumor angiogenesis. Cytokine Growth Factor Rev. 16:535–548. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dillon AK, Jevince AR, Hinck L, Ackerman
SL, Lu X, Tessier-Lavigne M and Kaprielian Z: UNC5C is required for
spinal accessory motor neuron development. Mol Cell Neurosci.
35:482–489. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim D and Ackerman SL: The UNC5C netrin
receptor regulates dorsal guidance of mouse hindbrain axons. J
Neurosci. 31:2167–2179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chédotal A, Kerjan G and Moreau-Fauvarque
C: The brain within the tumor: New roles for axon guidance
molecules in cancers. Cell Death Differ. 12:1044–1056. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thiebault K, Mazelin L, Pays L, Llambi F,
Joly MO, Scoazec JY, Saurin JC, Romeo G and Mehlen P: The netrin-1
receptors UNC5H are putative tumor suppressors controlling cell
death commitment. Proc Natl Acad Sci USA. 100:4173–4178. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mehlen P and Tauszig-Delamasure S:
Dependence receptors and colorectal cancer. Gut. 63:1821–1829.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Coissieux MM, Tomsic J, Castets M, Hampel
H, Tuupanen S, Andrieu N, Comeras I, Drouet Y, Lasset C,
Liyanarachchi S, et al: Variants in the netrin-1 receptor UNC5C
prevent apoptosis and increase risk of familial colorectal cancer.
Gastroenterology. 141:2039–2046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hibi K, Mizukami H, Shirahata A, Goto T,
Sakata M and Sanada Y: Aberrant methylation of the netrin-1
receptor genes UNC5C and DCC detected in advanced colorectal
cancer. World J Surg. 33:1053–1057. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lejmi E, Leconte L, Pédron-Mazoyer S,
Ropert S, Raoul W, Lavalette S, Bouras I, Feron JG, Maitre-Boube M,
Assayag F, et al: Netrin-4 inhibits angiogenesis via binding to
neogenin and recruitment of Unc5B. Proc Natl Acad Sci USA.
105:12491–12496. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koch AW, Mathivet T, Larrivée B, Tong RK,
Kowalski J, Pibouin-Fragner L, Bouvrée K, Stawicki S, Nicholes K,
Rathore N, et al: Robo4 maintains vessel integrity and inhibits
angiogenesis by interacting with UNC5B. Dev Cell. 20:33–46. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hong K, Hinck L, Nishiyama M, Poo MM,
Tessier-Lavigne M and Stein E: A ligand-gated association between
cytoplasmic domains of UNC5 and DCC family receptors converts
netrin-induced growth cone attraction to repulsion. Cell.
97:927–941. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Redig AJ and McAllister SS: Breast cancer
as a systemic disease: A view of metastasis. J Intern Med.
274:113–126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bernet A, Mazelin L, Coissieux MM, Gadot
N, Ackerman SL, Scoazec JY and Mehlen P: Inactivation of the UNC5C
Netrin-1 receptor is associated with tumor progression in
colorectal malignancies. Gastroenterology. 133:1840–1848. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fitamant J, Guenebeaud C, Coissieux MM,
Guix C, Treilleux I, Scoazec JY, Bachelot T, Bernet A and Mehlen P:
Netrin-1 expression confers a selective advantage for tumor cell
survival in metastatic breast cancer. Proc Natl Acad Sci USA.
105:4850–4855. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuan M, Guo H, Li J, Sui C, Qin Y, Wang J,
Khan YH, Ye L, Xie F, Wang H, et al: Slit2 and Robo1 induce
opposing effects on metastasis of hepatocellular carcinoma Sk-hep-1
cells. Int J Oncol. 49:305–315. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sørlie T, Perou CM, Tibshirani R, Aas T,
Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey
SS, et al: Gene expression patterns of breast carcinomas
distinguish tumor subclasses with clinical implications. Proc Natl
Acad Sci USA. 98:10869–10874. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Richardson AL, Wang ZC, De Nicolo A, Lu X,
Brown M, Miron A, Liao X, Iglehart JD, Livingston DM and Ganesan S:
X chromosomal abnormalities in basal-like human breast cancer.
Cancer Cell. 9:121–132. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Diagnosis and Treatment Guidelines For
Colorectal Cancer Working Group C: Chinese Society of Clinical
Oncology (CSCO) diagnosis and treatment guidelines for breast
cancer. 2017.In Chinese.
|
|
21
|
Song S, Peng P, Tang Z, Zhao J, Wu W, Li
H, Shao M, Li L, Yang C, Duan F, et al: Decreased expression of
STING predicts poor prognosis in patients with gastric cancer. Sci
Rep. 7:398582017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang C, Guo H, Li B, Sui C, Zhang Y, Xia
X, Qin Y, Ye L, Xie F, Wang H, et al: Effects of Slit3 silencing on
the invasive ability of lung carcinoma A549 cells. Oncol Rep.
34:952–960. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Li S, Quarto N, Senarath-Yapa K, Grey N,
Bai X and Longaker MT: Enhanced activation of canonical Wnt
signaling confers mesoderm-derived parietal bone with similar
osteogenic and skeletal healing capacity to neural crest-derived
frontal bone. PLoS One. 10:e01380592015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mao M, Alavi MV, Labelle-Dumais C, Gould
DB and Type IV: Type IV collagens and basement membrane diseases:
Cell biology and pathogenic mechanisms. Curr Top Membr. 76:61–116.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tryggvason K, Höyhtyä M and Pyke C: Type
IV collagenases in invasive tumors. Breast Cancer Res Treat.
24:209–218. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou R, Xu L, Ye M, Liao M, Du H and Chen
H: Formononetin inhibits migration and invasion of MDA-MB-231 and
4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through
PI3K/AKT signaling pathways. Horm Metab Res. 46:753–760. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim S, Choi JH, Lim HI, Lee SK, Kim WW,
Cho S, Kim JS, Kim JH, Choe JH, Nam SJ, et al: EGF-induced MMP-9
expression is mediated by the JAK3/ERK pathway, but not by the
JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line. Cell
Signal. 21:892–898. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim ES, Kim MS and Moon A:
TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38
MAPK, but not ERK signaling in MCF10A human breast epithelial
cells. Int J Oncol. 25:1375–1382. 2004.PubMed/NCBI
|
|
30
|
Li W, Liu Z, Zhao C and Zhai L: Binding of
MMP-9-degraded fibronectin to β6 integrin promotes invasion via the
FAK-Src-related Erk1/2 and PI3K/Akt/Smad-1/5/8 pathways in breast
cancer. Oncol Rep. 34:1345–1352. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rolli M, Fransvea E, Pilch J, Saven A and
Felding-Habermann B: Activated integrin alphavbeta3 cooperates with
metalloproteinase MMP-9 in regulating migration of metastatic
breast cancer cells. Proc Natl Acad Sci USA. 100:9482–9487. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chung J, Bachelder RE, Lipscomb EA, Shaw
LM and Mercurio AM: Integrin (alpha 6 beta 4) regulation of eIF-4E
activity and VEGF translation: A survival mechanism for carcinoma
cells. J Cell Biol. 158:165–174. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yebra M, Montgomery AM, Diaferia GR, Kaido
T, Silletti S, Perez B, Just ML, Hildbrand S, Hurford R,
Florkiewicz E, et al: Recognition of the neural chemoattractant
Netrin-1 by integrins alpha6beta4 and alpha3beta1 regulates
epithelial cell adhesion and migration. Dev Cell. 5:695–707. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gilcrease MZ, Zhou X, Lu X, Woodward WA,
Hall BE and Morrissey PJ: Alpha6beta4 integrin crosslinking induces
EGFR clustering and promotes EGF-mediated Rho activation in breast
cancer. J Exp Clin Cancer Res. 28:672009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee SS, Lee SJ, Lee SH, Ryu JM, Lim HS,
Kim JS, Song EJ, Jung YH, Lee HJ, Kim CH, et al: Netrin-1-induced
stem cell bioactivity contributes to the regeneration of injured
tissues via the lipid raft-dependent integrin α6β4 signaling
pathway. Sci Rep. 6:375262016. View Article : Google Scholar
|
|
36
|
Delcommenne M, Tan C, Gray V, Rue L,
Woodgett J and Dedhar S: Phosphoinositide-3-OH kinase-dependent
regulation of glycogen synthase kinase 3 and protein kinase B/AKT
by the integrin-linked kinase. Proc Natl Acad Sci USA.
95:11211–11216. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bernet A and Mehlen P: Dependence
receptors: When apoptosis controls tumor progression. Bull Cancer.
94:E12–E17. 2007.PubMed/NCBI
|
|
38
|
Paradisi A, Creveaux M, Gibert B, Devailly
G, Redoulez E, Neves D, Cleyssac E, Treilleux I, Klein C,
Niederfellner G, et al: Combining chemotherapeutic agents and
netrin-1 interference potentiates cancer cell death. EMBO Mol Med.
5:1821–1834. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Grandin M, Mathot P, Devailly G, Bidet Y,
Ghantous A, Favrot C, Gibert B, Gadot N, Puisieux I, Herceg Z, et
al: Inhibition of DNA methylation promotes breast tumor sensitivity
to netrin-1 interference. EMBO Mol Med. 8:863–877. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lipscomb EA, Simpson KJ, Lyle SR, Ring JE,
Dugan AS and Mercurio AM: The alpha6beta4 integrin maintains the
survival of human breast carcinoma cells in vivo. Cancer Res.
65:10970–10976. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bhatia V, Mula RV, Weigel NL and Falzon M:
Parathyroid hormone-related protein regulates cell survival
pathways via integrin alpha6beta4-mediated activation of
phosphatidylinositol 3-kinase/Akt signaling. Mol Cancer Res.
7:1119–1131. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
van Kempen LCL and Coussens LM: MMP9
potentiates pulmonary metastasis formation. Cancer Cell. 2:251–252.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Missan DS, Mitchell K, Subbaram S and
DiPersio CM: Integrin α3β1 signaling through MEK/ERK determines
alternative polyadenylation of the MMP-9 mRNA transcript in
immortalized mouse keratinocytes. PLoS One. 10:e01195392015.
View Article : Google Scholar
|
|
44
|
Sil H, Sen T and Chatterjee A:
Fibronectin-integrin (alpha5beta1) modulates migration and invasion
of murine melanoma cell line B16F10 by involving MMP-9. Oncol Res.
19:335–348. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lamar JM, Iyer V and DiPersio CM: Integrin
alpha3beta1 potentiates TGFbeta-mediated induction of MMP-9 in
immortalized keratinocytes. J Invest Dermatol. 128:575–586. 2008.
View Article : Google Scholar
|
|
46
|
Son TW, Yun SP, Yong MS, Seo BN, Ryu JM,
Youn HY, Oh YM and Han HJ: Netrin-1 protects hypoxia-induced
mitochondrial apoptosis through HSP27 expression via DCC- and
integrin α6β4-dependent Akt, GSK-3β, and HSF-1 in mesenchymal stem
cells. Cell Death Dis. 4:e5632013. View Article : Google Scholar
|
|
47
|
Lee SJ, Jung YH, Oh SY, Yong MS, Ryu JM
and Han HJ: Netrin-1 induces MMP-12-dependent E-cadherin
degradation via the distinct activation of PKCα and FAK/Fyn in
promoting mesenchymal stem cell motility. Stem Cells Dev.
23:1870–1882. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Taherian A, Li X, Liu Y and Haas TA:
Differences in integrin expression and signaling within human
breast cancer cells. BMC Cancer. 11:2932011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chisholm A and Tessier-Lavigne M:
Conservation and divergence of axon guidance mechanisms. Curr Opin
Neurobiol. 9:603–615. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Harburger DS and Calderwood DA: Integrin
signalling at a glance. J Cell Sci. 122:159–163. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li W, Aurandt J, Jürgensen C, Rao Y and
Guan KL: FAK and Src kinases are required for netrin-induced
tyrosine phosphorylation of UNC5. J Cell Sci. 119:47–55. 2006.
View Article : Google Scholar
|
|
52
|
Li W, Lee J, Vikis HG, Lee SH, Liu G,
Aurandt J, Shen TL, Fearon ER, Guan JL, Han M, et al: Activation of
FAK and Src are receptor-proximal events required for netrin
signaling. Nat Neurosci. 7:1213–1221. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Aikawa R, Nagai T, Kudoh S, Zou Y, Tanaka
M, Tamura M, Akazawa H, Takano H, Nagai R and Komuro I: Integrins
play a critical role in mechanical stress-induced p38 MAPK
activation. Hypertension. 39:233–238. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Huang D, Khoe M, Befekadu M, Chung S,
Takata Y, Ilic D and Bryer-Ash M: Focal adhesion kinase mediates
cell survival via NF-kappaB and ERK signaling pathways. Am J
Physiol Cell Physiol. 292:C1339–C1352. 2007. View Article : Google Scholar
|
|
55
|
Chen HC, Appeddu PA, Isoda H and Guan JL:
Phosphorylation of tyrosine 397 in focal adhesion kinase is
required for binding phosphatidylinositol 3-kinase. J Biol Chem.
271:26329–26334. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Acconcia F, Barnes CJ, Singh RR, Talukder
AH and Kumar R: Phosphorylation-dependent regulation of nuclear
localization and functions of integrin-linked kinase. Proc Natl
Acad Sci USA. 104:6782–6787. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Persad S, Attwell S, Gray V, Mawji N, Deng
JT, Leung D, Yan J, Sanghera J, Walsh MP and Dedhar S: Regulation
of protein kinase B/Akt-serine 473 phosphorylation by
integrin-linked kinase: Critical roles for kinase activity and
amino acids arginine 211 and serine 343. J Biol Chem.
276:27462–27469. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Troussard AA, Costello P, Yoganathan TN,
Kumagai S, Roskelley CD and Dedhar S: The integrin linked kinase
(ILK) induces an invasive phenotype via AP-1 transcription
factor-dependent upregulation of matrix metalloproteinase-9
(MMP-9). Oncogene. 19:5444–5452. 2000. View Article : Google Scholar : PubMed/NCBI
|
